CURATE.AI Optimized Modulation for Multiple Myeloma

NCT03759093 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone
OTHER: CURATE.AI-Guided dosage modulation
DRUG: Thalidomide
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Thalidomide
DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Lenalidomide

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]